Given the pleiotropic metabolic benefits elicited by Nrg4, biologic therapeutics targeting this pathway may provide an effective treatment that simultaneously targets type 2 diabetes and NAFLD in patients. Here, NRG4 is linked to type 2 diabetes mellitus.